Riboxin in complex therapy in children with allergodermatoses
- Authors: Malanicheva T.G.1, Shamova A.G.1, Shamov B.A.1
-
Affiliations:
- Kazan State Medical University
- Issue: Vol 79, No 5 (1998)
- Pages: 370-372
- Section: Articles
- URL: https://journals.rcsi.science/kazanmedj/article/view/64578
- DOI: https://doi.org/10.17816/kazmj64578
- ID: 64578
Cite item
Full Text
Abstract
The use of riboxin in atopic dermatosis and urticaria allows to increase significantly the efficiency of the treatment: to decrease the acute period and hospitalization time of children as well as to increase the remission time. The use of riboxin is recommended in the treatment and rehabilitation of children with acute and chronic forms of allergodermatoses.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
T. G. Malanicheva
Kazan State Medical University
Author for correspondence.
Email: info@eco-vector.com
Department of Pediatric Diseases, Faculty of General Medicine, Department of Dermatovenereology
Russian Federation, KazanA. G. Shamova
Kazan State Medical University
Email: info@eco-vector.com
Professor, Head of the Department of Childhood Diseases, Faculty of General Medicine, Department of Dermatovenereology
Russian Federation, KazanB. A. Shamov
Kazan State Medical University
Email: info@eco-vector.com
Department of Pediatric Diseases, Faculty of General Medicine, Department of Dermatovenereology
Russian Federation, KazanReferences
Supplementary files
